References
- 1. Anlar S., Capan Y., Hincal A.A.: Physico-chemical and bio-adhesive properties of polyacrylic acid polymers. Pharmazie, 48, 285, 1993.
- 2. Shaikh R. et al.: Muco-adhesive Drug Delivery Systems. J. Pharm. Bioall. Sci. 3, 89, 2011.
- 3. Brunet J. et al.: Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat. Eur. J. Pharmacol. 358, 213, 1998.
- 4. Cuevas P. et al.: Dobesilate is an angiogenesis inhibitor. Eur. J. Med. Res., 10, 369, 2005.
- 5. Cuevas P. et al.: Topical dobesilate eye drops for ophthalmic primary pterygium. BMJ Case Rep. 2012 Mar 8;2012. pii: bcr1220115449. doi: 10.1136/bcr.12.2011.5449.
- 6. Cuevas P. et al.: Treatment of Stargardt disease with dobesilate. BMJ Case Rep. 2012 Oct 12;2012. pii: bcr2012007128. doi: 10.1136/ bcr-2012-007128..
- 7. Cuevas P., Arrazola J. M.: Treatment of basal cell carcinoma with dobesilate. J. Am. Dermatol., 53, 526, 2005.
- 8. Dash S. et al.: Kinetic modeling on drug release from controlled drug delivery system. Acta Pol. Pharm. 67, 217, 2010.
- 9. Dick I. P., Scott R. C.: Pig Ear Skin as an In-vitro Model for Human Skin Permeability. J. Pharm. Pharmacol., 44, 640, 1992.
- 10. European Pharmacopoeia 7.0, 2.9.4: Dissolution test for transdermal patches, 01/2008:20904, 2011.
- 11. Fuchs E., Raghavan S.: Getting under the skin of epidermal morphogenesis. Nature Rev. Gen., 3, 199, 2002.
- 12. Genç L., Oğuzlar C., Güler E.: Studies on vaginal bio-adhesive tablets of acyclovir. Pharmazie, 55, 297, 2000.
- 13. Graber R. et al.: Calcium Dobesilate protects human peripheral blood mononuclear cells from oxidation and apoptosis. Apoptosis, 3, 41, 1998.
- 14. Hamishehkar H. et al.: The Relationship between Solubility and Transdermal Absorption of Tadalafil. Adv. Pharm. Bull., 5, 411, 2015.
- 15. Herkenne C. et al.: Pig ear skin ex-vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm. Res., 23, 1850, 2006.
- 16. Hu G. et al.: Selective electrochemical sensing of calcium dobesilate based on an ordered mesoporous carbon-modified pyrolytic graphite electrode. J. Electroanal. Chem., 633, 264, 2009.
- 17. Iriz E. et al.: Effects of calcium dobesilate and diosmin-hesperidin on apoptosis of venous wall in primary varicose veins. Vasa, 37, 233, 2008.
- 18. Jacobi U. et al.: Porcine ear skin: an in-vitro model for human skin. Skin Res. Technol., 13, 19, 2007.
- 19. Jafferany M. et al.: Geriatric dermatoses: a clinical review of skin diseases in an aging population. Int. J. Dermatol., 51, 509, 2012.
- 20. Kaur C. et al.: An open trial of calcium dobesilate with venous ulcers and stasis dermatitis. Int. J. Dermatol., 42, 147, 2003.
- 21. Kendall M. et al.: Effects of Relative Humidity and Ambient Temperature on the Ballistic Delivery of Micro-Particles to Excised Porcine Skin. J. Investig. Dermatol., 122, 739, 2004.
- 22. Kong R., Bhargava R.: Characterization of porcine skin as a model for human skin studies, using infrared spectroscopic imaging. Analyst, 136, 2359, 2011.
- 23. Lisik A. et al.: Effect of standard and reversible arrangements of Ph.Eur./USP extraction cells during dissolution tests of calcium dobesilate in hydrogel formulation. Curr. Issues Pharm. Med. Sci., 28, 136, 2015.
- 24. Morimoto N. et al.: The Rapid Inactivation of Porcine Skin by Applying High Hydrostatic Pressure without Damaging the Extracellular Matrix. BioMed Res. Int., 2015, Article ID 587247, 2015.
- 25. Reddy D. N. et al.: Design, development and characterization of clopidogrel bisulfate transdermal drug delivery system - Asian J. Pharm. Clin. Res., 8, 277, 2015.
- 26. Rota R. et al.: Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur. J.Pharmacol., 495, 217, 2004.
- 27. Ruiz E., Lorente R., Tejerina T.: Effects of calcium dobesilate on the synthesis of endothelium-dependent relaxing factors in rabbit isolated aorta. Brit. J. Pharmacol., 121, 711, 1997.
- 28. Sekkat N., Kalia Y.N., Guy R.H.: Porcine Ear Skin as a Model for the Assessment of Transdermal Drug Delivery to Premature Neonates. Pharm. Res., 21, 1390, 2004.
- 29. Siepmann J., Peppas N. A.: Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev., 48, 139, 2001.
- 30. Summerfield A., Meurens F., Ricklin M.E.: The immunology of the porcine skin and its value as a model for human skin. Molec. Immunol., 66, 14, 2015.
- 31. Suschek C., Kolb H., Kolb-Bachofen V.: Dobesilate enhances endothelial nitric oxide synthase-activity in macro- and microvascular endothelial cells. Brit. J. Pharmacol., 122, 1502, 1997.
- 32. Tejerina T., Ruiz E.: Calcium Dobesilate: Pharmacology and Future Approaches. Gen. Pharmacol., 31, 357, 1998.
- 33. Žilius M., Ramanauskienė K., Briedis V.: Release of Propolis Phenolic Acids from Semisolid Formulations and Their Penetration into the Human Skin In Vitro, J. Evid. Based Complementary Altern. Med., 2013, Article ID 958717, 2013, doi:10.1155/2013/958717.